简体中文
|
繁體中文
|
English
Business Wire Global sites
Business Wire Global
UK/Ireland
Deutschland
France
Italy
Japan
Home
News
Events
Media Services
About Us
Contact Us
Health and Pharmaceutical Press Releases
2015-09-30 12:11
New data demonstrate sustained long-term efficacy of OFEV®* on slowing disease progression and safety in patients with IPF
2015-09-29 14:28
Takeda Pharmaceutical: New Drug Application Approval in Japan for Copaxone® Subcutaneous Injection 20 mg Syringe, a Drug for the Treatment of Multiple Sclerosis
2015-09-29 10:13
COPD: New Data Support Role of Spiolto® Respimat® as 1st-line Maintenance Therapy and Show Superiority over LABA/ICS
2015-09-29 10:07
Takeda Selected for the Sixth Consecutive Year for Dow Jones Sustainability Asia Pacific Index
2015-09-28 16:43
Masimo Donates $5 Million in Medical Equipment to Assist Jordan in Providing Healthcare to Over 1 Million Syrian Refugees
2015-09-28 14:18
CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)
2015-09-28 10:03
VARGATEF® plus docetaxel significantly reduced tumour burden in lung cancer patients with advanced adenocarcinoma compared to docetaxel alone
2015-09-28 09:58
ECC 2015: GIOTRIF® (afatinib) demonstrates superior survival compared to Tarceva® (erlotinib) for patients with previously treated advanced squamous cell carcinoma of the lung, independent of EGFR mutation status
2015-09-28 09:52
Merck and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma
2015-09-25 16:56
Shiseido's Social Business Model in Bangladesh Recognized as Initiative of "Business Call to Action (BCtA)" Led by United Nations Development Programme
2015-09-25 15:44
Celgene’s VIDAZA® (Azacitidine for Injection) Receives Positive CHMP Opinion as New Treatment for Elderly Patients with Acute Myeloid Leukaemia
2015-09-25 11:32
Opening of Mars, Incorporated Global Food Safety Center Signals Invitation for Collaboration
2015-09-25 10:09
Merck and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab
2015-09-24 14:19
EOS imaging Announces Second Installation in Hong Kong
2015-09-23 17:07
Takeda to Highlight Ixazomib Clinical Development Program at Upcoming International Myeloma Workshop
2015-09-21 16:29
Boehringer Ingelheim and BioMed X apply crowdsourcing to establish a team of scientists for identifying key epigenetic regulators of COPD
2015-09-21 15:12
Joe Kiani to Deliver Keynote Remarks at the Heidelberg Interdisciplinary Patient Safety Symposium
2015-09-21 14:18
ERS 2015: Landmark year for Boehringer Ingelheim’s respiratory portfolio - new data for COPD, IPF and asthma treatments
2015-09-21 14:03
Arcadia Biosciences, Bioceres and TMG to Develop Soybeans with Non-GM Agronomic and Product Quality Traits Through New Collaboration
2015-09-21 13:52
ProZyme, Inc. and BiOptic, Inc. Sign Licensing Agreement to Develop Gly-Q System for Glycan Analysis
<< First
< Previous
235
236
237
238
239
240
241
242
243
244
Next >
Last >>
30660
30655
30652
30651
30646
30641
30640
30639
30638
30635
30633
30630
30627
30619
30615
30596
30594
30592
30591
30590
Business Wire Weibo
Press Releases
Corporate Social Responsibility
Manufacturing
Chemical
Health and Pharmaceutical
Property
Travel
Automotive
Life and Entertainment
Energy and Environmental
Retail
Transportation
Business and E-commerce
Communications and Media
Metals and Mining
Finance
Technology
Sports
Education
Art and Culture
Legal
Latest Releases
2026-05-09 17:08
Datavault AI Announces Board of Directors Has Requested Management’s Complete Plan for Dividend Spin-Out of Acoustic Sciences Division into Stand-Alone Public Company
2026-05-09 16:53
UAE Commits $49bn to Local Manufacturers
2026-05-09 16:51
Twilio’s Next Generation Platform: An Infrastructure Layer for Every Conversation in the Agentic Era
2026-05-09 16:48
Beneq Appoints Dr. Jason Harrison as Chief Executive Officer
2026-05-09 16:44
Asset Value Investors (AVI) Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage More Constructively with Shareholders